Physician

Khoi M Dao, MD

According to 2025 Medicare claims, Khoi Dao, MD (NPI: 1518071208) practices medical oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89052-3908.

Dao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,048 traditional Medicare patients, billed 246,886 HCPCS/CPT codes, and received $2,850,688 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,081 prescription claims across 181 beneficiaries totaling $2,078,753 in drug costs, led by Lenalidomide (Lenalidomide). 2022 DME data shows 11 claims. Open Payments data shows 155 records totaling $2,576. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	996	303,705	$2,852,114
2016	1,105	338,870	$3,452,687
2017	1,152	243,349	$2,845,370
2018	1,214	244,465	$2,606,277
2019	1,289	309,498	$2,923,326
2020	1,082	271,041	$2,476,059
2021	1,081	294,586	$2,763,024
2022	1,071	282,473	$2,846,827
2023	1,060	299,865	$3,020,138
2024	1,048	246,886	$2,850,688

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	1,110	$1,244,294
2016	241	1,397	$1,821,174
2017	219	1,164	$1,565,699
2018	171	921	$1,664,264
2019	189	958	$2,084,568
2020	192	921	$1,783,708
2021	190	1,008	$1,724,916
2022	186	1,018	$1,785,768
2023	192	1,065	$1,830,238
2024	181	1,081	$2,078,753

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	213	$46,990
2016	N/R	82	$36,758
2017	N/R	23	$2,412
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	57	$4,023
2021	N/R	29	$2,847
2022	N/R	11	$798
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	537	1,032	$69
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	251	295	$38
80053	Blood test, comprehensive group of blood chemicals	542	1,162	$10
36415	Insertion of needle into vein for collection of blood sample	676	1,789	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	606	1,772	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	57	1,571	$855,566
Revlimid	Lenalidomide	15	413	$256,439
Xtandi	Enzalutamide	15	450	$213,224
Ibrance	Palbociclib	11	308	$161,198
Xarelto	Rivaroxaban	73	4,800	$88,352

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	155	$2,576	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Khoi M. Dao, MD?

Tedicare shows public-source Medicare data for Khoi M. Dao, MD (NPI 1518071208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khoi M. Dao, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Khoi M. Dao, MD?

Khoi M. Dao, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Khoi M. Dao, MD have Open Payments data?

Khoi M. Dao, MD has 155 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.